These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6652491)

  • 21. Dose-related influence of arginine-vasopressin on a passive avoidance behavior: effect of rearing conditions.
    Crine AF
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):379-84. PubMed ID: 6541358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facilitation of memory consolidation by vasopressin: mediation by terminals of the dorsal noradrenergic bundle?
    Kovács GL; Bohus B; Versteeg DH
    Brain Res; 1979 Aug; 172(1):73-85. PubMed ID: 466468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive avoidance behavior, vasopressin and the immune system. A link between avoidance latency and immune response.
    Croiset G; Heijnen CJ; de Wied D
    Neuroendocrinology; 1990 Feb; 51(2):156-61. PubMed ID: 2106096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptidergic transmission in the brain. II. Mediation by a vasopressin-like peptide.
    Smock T; Albeck D; McMechen P; Purves D
    Brain Res; 1990 Mar; 511(1):15-20. PubMed ID: 2331612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurogenesis of galanin cells in the bed nucleus of the stria terminalis and centromedial amygdala in rats: a model for sexual differentiation of neuronal phenotype.
    Han TM; De Vries GJ
    J Neurobiol; 1999 Mar; 38(4):491-8. PubMed ID: 10084684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sexual differentiation of vasopressin projections of the bed nucleus of the stria terminals and medial amygdaloid nucleus in rats.
    Wang Z; Bullock NA; De Vries GJ
    Endocrinology; 1993 Jun; 132(6):2299-306. PubMed ID: 8504734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Septal vasopressin modulates motility and passive avoidance in pinealectomized rats.
    Appenrodt E; Schwarzberg H
    Physiol Behav; 1999 Jul; 66(5):757-61. PubMed ID: 10405103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-OHDA bilateral lesions to the central amygdala do not affect vasopressin improvement of recall in rats.
    Winnicka MM
    Acta Neurobiol Exp (Wars); 1996; 56(4):943-8. PubMed ID: 9033129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptidergic transmission in the brain. I. Vasopressin-like signal in the hippocampus.
    Albeck D; Smock T; McMechen P; Purves D; Floyd L
    Brain Res; 1990 Mar; 511(1):7-14. PubMed ID: 2331618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonally active arginine-vasopressin suppresses endotoxin-induced fever in rats: lack of effect of oxytocin and a behaviorally active vasopressin fragment.
    Kovács GL; De Wied D
    Neuroendocrinology; 1983 Oct; 37(4):258-61. PubMed ID: 6355890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of vasopressin analog [d(CH2)1(5),Tyr(Me)2]AVP on learning and memory in rats chronically treated with ethanol.
    Car H; Borawska MH; Wiśniewski K
    Pol J Pharmacol; 1993; 45(5-6):503-12. PubMed ID: 8012473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vasopressin and analogue [d(CH2)1(5), Tyr (Me)2, Val4, delta 3Pro7)] AVP on learning and memory in rats chronically treated with ethanol.
    Car H; Borawska MH; Wiśniewski K
    J Physiol Pharmacol; 1994 Mar; 45(1):163-71. PubMed ID: 8043905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of a reminder cue on amnesia induced by stimulation of amygdala and hippocampus.
    Baker LJ; Kesner RP; Michal RE
    J Comp Physiol Psychol; 1981 Apr; 95(2):312-21. PubMed ID: 7229162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution and morphology of vasopressin-, neurophysin II-, and oxytocin-immunoreactive cell bodies in the forebrain of the cat.
    Caverson MM; Ciriello J; Calaresu FR; Krukoff TL
    J Comp Neurol; 1987 May; 259(2):211-36. PubMed ID: 3294931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synaptic innervation to rat hippocampus by vasopressin-immuno-positive fibres from the hypothalamic supraoptic and paraventricular nuclei.
    Zhang L; Hernández VS
    Neuroscience; 2013 Jan; 228():139-62. PubMed ID: 23085097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Memory effects of arginine vasopressin (AVP) and [7-9] fragment of its peptide chain in rats.
    Klimkiewicz T
    Acta Neurobiol Exp (Wars); 2001; 61(4):267-76. PubMed ID: 11905148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal administration of vasopressin antiserum induces long-term deficits on active and passive avoidance behaviour in rats.
    Moratalla R; Borrell J; Sanchez-Franco F; Del Rio J
    Behav Brain Res; 1987 Mar; 23(3):231-7. PubMed ID: 3580108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further evidence for a dissociation of peripheral and central effects of vasopressin.
    Gaffori O; de Wied D
    Psychoneuroendocrinology; 1985; 10(4):439-44. PubMed ID: 4089084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressin and oxytocin in brain areas of rats selectively bred for differences in behavioral performance.
    Hess J; Lesser D; Landgraf R
    Brain Res; 1992 Jan; 569(1):106-11. PubMed ID: 1611470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasopressin: site of behavioral action and role in human mental performance.
    Van Wimersma Greidanus TB; Veldhuis HD
    Peptides; 1985; 6 Suppl 2():177-80. PubMed ID: 4080615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.